SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (3043)7/20/2020 2:26:42 PM
From: Miljenko Zuanic  Respond to of 3557
 
OF Topic, CueVac
CVnCoV Vaccine, dose levels of 2, 4 and 8 µg
(Germany Gov in full support of this development)

clinicaltrials.gov



To: Miljenko Zuanic who wrote (3043)7/20/2020 10:48:03 PM
From: Felix B  Read Replies (1) | Respond to of 3557
 
I haven't found the vaccine front to closely but it seems like their nAb levels drop off after 2 weeks for all that have disclosed data? Doesn't mean memory B-cell can ramp up but now I am really curious REGN cocktail PK data.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News